Ana Custodio

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

Jaume Capdevila, Nicola Fazio, Carlos López et al. · Journal of Clinical Oncology · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +16

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

Paula Jiménez Fonseca, Alberto Carmona‐Bayonas, Raquel Hernández et al. · British Journal of Cancer · 2017 · 103 citations · Full text

Medicine, Oncology, Chemotherapy +12

Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients

Juan Antonio Cruzado, Sonia López-Santiago, Virginia Martínez-Marín et al. · Supportive Care in Cancer · 2014 · 102 citations

Medicine, Oncology, Psychology +17

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

Barbara Nuñez-Valdovinos, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al. · The Oncologist · 2018 · 92 citations · Full text

Medicine, Oncology, Pathology +17

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors

Ramón Salazar, Rocio García‐Carbonero, Steven K. Libutti et al. · The Oncologist · 2017 · 77 citations · Full text

Medicine, Oncology, Pharmacology +13